Edition:
United States

Neuren Pharmaceuticals Ltd (NEU.AX)

NEU.AX on Australia Stock Exchange

0.05AUD
29 Sep 2016
Change (% chg)

-- (--)
Prev Close
$0.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,219,870
52-wk High
$0.13
52-wk Low
$0.04

NEU.AX

Chart for NEU.AX

About

Neuren Pharmaceuticals Limited (Neuren) is a biopharmaceutical company engaged in developing drugs for neurological disorders. The Company develops therapies for brain injury, neurodevelopmental and neurodegenerative disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic... (more)

Overall

Beta: 1.44
Market Cap(Mil.): $86.50
Shares Outstanding(Mil.): 1,729.93
Dividend: --
Yield (%): --

Financials

  NEU.AX Industry Sector
P/E (TTM): -- 44.84 37.54
EPS (TTM): -0.01 -- --
ROI: -134.63 -0.27 13.98
ROE: -134.63 -2.93 14.88

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.